Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 11 , ISSUE 1 ( January-March, 2022 ) > List of Articles

Original Article

A Comparative Study of Cartridge-based Nucleic Acid Amplification Test and ZiehlÂ-Neelsen Stain with Culture on LowensteinÂ-Jensen Media as Gold Standard for the Diagnosis of Pulmonary Tuberculosis

Rohon Das Roy, Subhayan Das Gupta

Keywords : Acid-fast bacilli, cartridge-based nucleic acid amplification test, LowensteinÂ-Jensen media, Mycobacterium tuberculosis

Citation Information : Roy RD, Gupta SD. A Comparative Study of Cartridge-based Nucleic Acid Amplification Test and ZiehlÂ-Neelsen Stain with Culture on LowensteinÂ-Jensen Media as Gold Standard for the Diagnosis of Pulmonary Tuberculosis. Indian J Respir Care 2022; 11 (1):39-42.

DOI: 10.4103/ijrc.ijrc_123_21

License: CC BY-NC-SA 4.0

Published Online: 06-12-2022

Copyright Statement:  Copyright © 2022; Indian Journal of Respiratory Care.


Introduction: Tuberculosis (TB) is an airborne disease caused by Mycobacterium tuberculosis that usually affects the lungs, leading to fever, cough, and chest pain. Although a declining trend was observed in most developed countries, TB remains a leading cause of morbidity and mortality in many developing countries, including India. Materials and Methods: This prospective study was carried out using 150 sputum samples of suspected pulmonary TB patients. All the samples were subjected to ZiehlÂ-Neelsen stain, cartridge-based nucleic acid amplification test (CBNAAT) and culture on LowensteinÂ-Jensen (LJ) media. They were compared for sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) in terms of quantitative results. Results: CBNAAT results of the sputum samples showed a sensitivity of 100%, 88.7% specificity, 90.3% PPV, and NPV 94%, whereas culture on LJ media showed a sensitivity, specificity, PPV, and NPV of 68.3%, 100%, 100%, and 73.9%, respectively. Conclusion: Whereas culture remains the gold standard for the diagnosis of TB, CBNAAT has taken over the domain of diagnosis owing to its high sensitivity and rapid turn over time.

  1. World Health Organization, WHO Global Tuberculosis Report 2020, Executive Summary. Vol 1. Geneva: World Health Organization; 2020.
  2. Jacobs RF. Multiple-drug-resistant tuberculosis. Clin Infect Dis 1994;19:1-8.
  3. Tuberculosis Coalition for Technical Assistance. International Standards for Tuberculosis Care (ISTC). 2nd ed. The Hague: Tuberculosis Coalition for Technical Assistance; 2009.
  4. Toman K. How many bacilli are present in a sputum specimen found positive by smear microscopy? In: Frieden T, editor. TomanÂ's Tuberculosis: Case Detection, Treatment, and Monitoring Â- Questions and Answers. WHO/HTM/TB/2004. 2nd ed. Geneva: World Health Organization; 2004. p. 11-3.
  5. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: A systematic review. Lancet Infect Dis 2006;6:570-81.
  6. World Health Organization. Policy Statement: Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System. WHO/HTM/TB/2011. Geneva: World Health Organization;
  7. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010;48:229-37.
  8. Miotto P, Bigoni S, Migliori GB, Matteelli A, Cirillo DM. Early tuberculosis treatment monitoring by Xpert® MTB/RIF. Eur Respir J 2012;39:1269-71.
  9. World Health Organization. Policy Framework for Implementing New Tuberculosis Diagnostics. Geneva: World Health Organization; 2011.
  10. Xpert MTB/RIF Manual, Cepheid. GENE XPERT MTB RIF USER MANUAL Pdf; 2013. Available from: [Last accessed on 2021 May 03].
  11. Stinson KW, Eisenach K, Kayes S, Matsumoto M, Siddiqi S, Nakashima S, et al. Mycobacteriology Laboratory Manual. Publication of Global Laboratory Initiative a Working Group of the Stop TB Partnership. 1st ed. April; 2014.
  12. Agrawal M, Bajaj A, Bhatia V, Dutt S. Comparative study of GeneXpert with ZN stain and culture in samples of suspected pulmonary tuberculosis. J Clin Diagn Res 2016;10:C09-12.
  13. Sharma SK, Kohli M, Yadav RN, Chaubey J, Bhasin D, Sreenivas V, et al. Evaluating the diagnostic accuracy of Xpert MTB/RIF assay in pulmonary tuberculosis. PLoS One 2015;10:e0141011.
  14. Afsar I, Gunes M, Er H, Gamze Sener A. Comparison of culture, microscopic smear and molecular methods in diagnosis of tuberculosis. Rev Esp Quimioter 2018;31:435-8.
  15. Reechaipichitkul W, Suleesathira T, Chaimanee P. Comparıson of genexpert MTB/RIF assay with conventional AFB smear for dıagnosıs of pulmonary tuberculosıs ın northeastern Thailand. Southeast Asian J Trop Med Public Health 2017;48:313-21.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.